Melinta Therapeutics, Inc. Receivables Turnover Ratio (CEMP), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Melinta Therapeutics, Inc.  (CEMP)
 

Melinta Therapeutics Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Melinta Therapeutics, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 4.32, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2019. Average receivable collection period, for the Melinta Therapeutics in Sep 30 2019 quarter, has decreased to 84 days, compared to 87 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 407 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 3003 to 3004.

What is Receivable Turnover Ratio?
What is Melinta Therapeutics, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEMP Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change -51.33 % -7.42 % -34.94 % 48.63 % 1287.94 %
Y / Y Revenue Change -53.43 % 32.72 % -5.1 % 738.79 % 967.94 %
Receivable Turnover Ratio (TTM) 4.32 4.18 3.95 3.68 2.67
CEMP's Total Ranking # 3004 # 3003 # 3003 # 3002 # 0
Accounts Receivable average collection period days 85 87 92 99 137
Seq. Receivable Change -0.78 % 28.13 % -33.77 % -42.2 % 88.76 %
Seq. Revenue Change -0.53 % 13.28 % -60.31 % 4.14 % 183.46 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 408
Overall Market # 3004

Receivable Turnover Ratio Statistics
High Average Low
0.22 0.14 0.07
(Jun 30 2019)   (Jun 30 2016)





CEMP Company Profile • Back to CEMP Efficiency Comparisons • Compare CEMP Receivables Turnover Ratio to its Competitors

Financial Statements
Melinta Therapeutics's Accounts Receivable $ 19 Millions Visit CEMP's Balance sheet
Melinta Therapeutics's Sales TTM $ 81 Millions Visit CEMP's Income Statement
Sources of CEMP's Revenues Visit CEMP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CEMP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CEMP's Growth Rates CEMP's Roa CEMP's Inventory Turnover Ratio CEMP's Dividend Comparisons
CEMP's Profitability Ratios CEMP's Roi CEMP's Asset Turnover Ratio CEMP's Dividend Growth
CEMP's Valuation Ratios CEMP's Roe CEMP's Financial Strength Ratios CEMP's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Ontrak Inc   11.78 $ 28.961  Millions$ 2.458  Millions
Exact Sciences Corporation  11.69 $ 723.699  Millions$ 61.882  Millions
The Pennant Group Inc   11.69 $ 88.398  Millions$ 7.562  Millions
Karyopharm Therapeutics Inc   11.61 $ 23.003  Millions$ 1.982  Millions
Rigel Pharmaceuticals Inc  11.60 $ 81.745  Millions$ 7.044  Millions
Neuronetics Inc   11.50 $ 60.935  Millions$ 5.300  Millions
Paratek Pharmaceuticals Inc   11.22 $ 24.594  Millions$ 2.192  Millions
China Pharma Holdings Inc  11.09 $ 11.118  Millions$ 1.003  Millions
Surmodics Inc   10.98 $ 100.077  Millions$ 9.112  Millions
Tivity Health Inc   10.88 $ 1,011.405  Millions$ 92.931  Millions
Scienture Holdings Inc   10.88 $ 7.034  Millions$ 0.647  Millions
Akebia Therapeutics Inc   10.52 $ 325.296  Millions$ 30.911  Millions
Teladoc Health Inc   10.52 $ 519.559  Millions$ 49.405  Millions
Glaukos Corp  10.51 $ 225.211  Millions$ 21.420  Millions
Insulet Corporation  10.51 $ 693.713  Millions$ 65.990  Millions
Catalyst Pharmaceuticals Inc   10.49 $ 72.684  Millions$ 6.931  Millions
Rockwell Medical inc   10.36 $ 62.667  Millions$ 6.051  Millions
Myomo Inc   10.28 $ 3.207  Millions$ 0.312  Millions
Procyon Corporation  10.26 $ 4.284  Millions$ 0.417  Millions
National Healthcare Corp  10.24 $ 991.423  Millions$ 96.845  Millions
Acorda Therapeutics Inc   10.22 $ 211.064  Millions$ 20.661  Millions
Sutro Biopharma Inc   10.18 $ 50.517  Millions$ 4.965  Millions
Acadia Pharmaceuticals Inc   10.13 $ 300.321  Millions$ 29.658  Millions
Patterson Companies Inc   10.09 $ 5,580.846  Millions$ 553.306  Millions
Fresh Tracks Therapeutics Inc   10.05 $ 7.372  Millions$ 0.733  Millions
Icagen, Inc.  9.95 $ 14.084  Millions$ 1.416  Millions
Delcath Systems Inc   9.94 $ 2.085  Millions$ 0.210  Millions
Kyto Technology And Life Science Inc   9.84 $ 0.018  Millions$ 0.002  Millions
Semler Scientific inc   9.77 $ 29.581  Millions$ 3.028  Millions
Pacira Biosciences inc   9.75 $ 393.717  Millions$ 40.372  Millions

Date modified: 2026-09-26T06:56:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.